Medpace Clinical Pharmacology Unit

Cincinnati, Ohio 45227

2 studies enrolling now · 38 studies all time

What they study most

ARDS, Alpha 1-Antitrypsin Deficiency, Alzheimer Disease, Anemia, Iron Deficiency, Bacterial Pneumonia, Chronic Pain, Community-acquired Pneumonia, Coronary Artery Disease, Covid19, Covid19-associated ARDS, Diabetes Mellitus, Type 2, Diabetes Melliuts, Type 2

Studies at this site

• A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants — Recruiting now
• First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults — Recruiting now
• A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers — Running, not enrolling
• Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants — Running, not enrolling
• Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers — Completed
• A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers — Completed
• Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults — Completed
• A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults — Completed
• RTA 408 Lotion in Healthy Volunteers — Completed
• A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 — Stopped early
• A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria — Withdrawn before enrolling
• Study of the Safety, Tolerability, and Pharmacokinetics of NUV001 Administered Orally to Healthy Adult Participants — Completed
• A Study Comparing Two Subcutaneous Formulations: Vial and Autoinjector (AI) With Olezarsen, at Two Dose Levels, in Healthy Adult Participants — Completed
• A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants — Completed
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy Volunteers — Stopped early
• Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects — Completed
• Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects — Completed
• Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria — Status unconfirmed
• Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers — Completed
• Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults — Completed
• Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers — Completed
• Prasugrel/Clopidogrel Maintenance Dose Washout Study — Completed
• A First-in-Human Study of AV-001 in Healthy Subjects — Completed
• Atorvastatin Three Year Pediatric Study — Completed
• Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects — Completed
• Pharmacokinetic Study of Subcutaneous Testosterone Enanthate — Completed
• The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease — Completed
• Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease — Completed
• A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects — Completed
• A Multiple Ascending Dose Study of COR388 — Completed
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers — Completed
• A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia — Completed
• Study of COR388 HCl in Healthy Subjects — Completed
• Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes — Completed
• Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg — Completed
• Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus — Completed
• Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes — Completed
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol — Stopped early